Cobalt Single-Atom Nanozyme Co-Administration with Ascorbic Acid Enables Redox Imbalance for Tumor Catalytic Ablation

Guoyuan Ren, Mingju Lu, Zhiqiang Zhao, Fengjuan Qin, Kai Li, Wenxing Chen, Yuqing Lin*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

The elevated antioxidant defense system in cancer cells can lead to resistance to treatments involving ROS. Breaking the redox balance of the cell system through a “open up the source and regulate the flow” strategy can inhibit the growth of cancer cells and thus design a cancer treatment strategy. Here, cobalt single atom-supported N-doped carbon nanozymes (Co SA-N/C) were synthesized via a simple sacrificial template method, which can mimic the properties of ascorbate oxidase and glutathione oxidase effectively. The synthesized Co SA-N/C can induce the generation of active oxygen by accelerating the oxidation of ascorbic acid (AA) and destroy the endogenous active oxygen scavenging system by consuming the main antioxidant, glutathione (GSH). In-depth in vitro and in vivo investigations indicate that compared with solo therapy, Co SA-N/C together with AA can significantly enhance the anti-tumor efficiency by simultaneously elevating oxidative stress and consuming the overexpressed glutathione (GSH) through the redox reaction catalyzed by Co SA-N/C. This work provides a promising route for developing nanozyme-guided and ascorbate-based antitumor agents.

Original languageEnglish
Pages (from-to)1066-1076
Number of pages11
JournalACS Biomaterials Science and Engineering
Volume9
Issue number2
DOIs
Publication statusPublished - 13 Feb 2023

Keywords

  • ascorbic acid
  • cancer cell proliferation
  • glutathione
  • nanozyme
  • redox balance
  • single atom

Fingerprint

Dive into the research topics of 'Cobalt Single-Atom Nanozyme Co-Administration with Ascorbic Acid Enables Redox Imbalance for Tumor Catalytic Ablation'. Together they form a unique fingerprint.

Cite this